AGER and diabetic retinopathy: Soluble RAGE (sRAGE), a secreted isoform that acts as a competitive inhibitor of AGE-mediated alterations in cells, has been shown to inhibit diabetes-induced changes in retinal histology and in electroretinograms produced with an experimental model of diabetic retinopathy [9].